Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])
about
Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Should Antihypertensive Treatm ...... t Heart Attack Trial [ALLHAT])
@ast
Should Antihypertensive Treatm ...... t Heart Attack Trial [ALLHAT])
@en
type
label
Should Antihypertensive Treatm ...... t Heart Attack Trial [ALLHAT])
@ast
Should Antihypertensive Treatm ...... t Heart Attack Trial [ALLHAT])
@en
prefLabel
Should Antihypertensive Treatm ...... t Heart Attack Trial [ALLHAT])
@ast
Should Antihypertensive Treatm ...... t Heart Attack Trial [ALLHAT])
@en
P2093
P2860
P1476
Should Antihypertensive Treatm ...... t Heart Attack Trial [ALLHAT])
@en
P2093
ALLHAT Collaborative Research Group
Barry R Davis
Charles E Ford
Ekambaram Ilamathi
L Julian Haywood
Linda B Piller
M Sarah Baraniuk
Mahshid A Assadi
Michael H Alderman
Paula T Einhorn
P2860
P304
P356
10.1016/J.AMJCARD.2015.10.012
P407
P577
2015-10-19T00:00:00Z